May exhibit some atypia Adenocarcinomaincreased cellular atypia
Understanding their mechanism of action provides a framework for optimizing efficacy, minimizing side effects, and expanding applications beyond diabetes to include other areas such as the treatment of obesity, cardiovascular diseases, non-alcoholic fatty liver disease (NAFLD), and even neurodegeneration
This includes assessment of tissue resilience, inflammatory signaling, and regenerative capacity at the cellular level
If you have neurological symptoms (pins and needles, numbness, balance issues), severe fatigue, unexplained weight loss, chest pain, breathlessness, or symptoms that are worsening, you should seek medical assessment promptly.
:
Stopping Medication Too Early Because of Mild Side Effects Mild side effects like nausea, fullness, or constipation are common at the start of GLP-1 treatment and usually improve as the body adjusts